BA
TEVA icon

Boston Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Boston Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,644
Closed -$402K – 666
2019
Q1 		$402K Buy
25,644
+2,089
+9% +$36.8K 0.02% 504
2018
Q4 		$363K Buy
23,555
+3,592
+18% +$73.6K 0.02% 502
2018
Q3 		$430K Buy
+19,963
New +$463K 0.02% 500
2017
Q3 		– Sell
-7,850
Closed -$261K – 670
2017
Q2 		$261K Sell
7,850
-7,767
-50% -$240K 0.01% 596
2017
Q1 		$501K Sell
15,617
-1,855
-11% -$63.3K 0.01% 469
2016
Q4 		$633K Sell
17,472
-134,278
-88% -$5.36M 0.02% 432
2016
Q3 		$6.98M Sell
151,750
-1,998
-1% -$104K 0.17% 153
2016
Q2 		$7.72M Sell
153,748
-6,669
-4% -$355K 0.19% 144
2016
Q1 		$8.58M Buy
160,417
+601
+0.4% +$35.3K 0.21% 127
2015
Q4 		$10.5M Sell
159,816
-48
-0% -$2.97K 0.25% 124
2015
Q3 		$9.03M Sell
159,864
-1,893
-1% -$123K 0.34% 86
2015
Q2 		$9.56M Sell
161,757
-8,660
-5% -$534K 0.4% 81
2015
Q1 		$10.6M Buy
170,417
+160,867
+1,684% +$9.35M 0.42% 75
2014
Q4 		$549K Sell
9,550
-1,800
-16% -$100K 0.02% 331
2014
Q3 		$610K Hold
11,350
– – 0.03% 322
2014
Q2 		$595K Sell
11,350
-100
-0.9% -$5.11K 0.03% 332
2014
Q1 		$605K Sell
11,450
-2,550
-18% -$118K 0.03% 318
2013
Q4 		$561K Sell
14,000
-1,450
-9% -$57.1K 0.03% 330
2013
Q3 		$584K Sell
15,450
-3,550
-19% -$138K 0.03% 307
2013
Q2 		$745K Buy
+19,000
New +$740K 0.04% 276

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Advisors's TEVA Position: Q2 2019 in Review

Boston Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 25,644 shares — an estimated $402K sold.

Boston Advisors first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $10.6M in Q1 2015. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Boston Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
  • Boston Advisors sold 25,644 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $402K.
  • Boston Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 20 quarters.
  • Boston Advisors's Teva Pharmaceutical Industries Limited position peaked at $10.6M in Q1 2015.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Boston Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.